Related Experiment Videos

Cardiorenal consequences of atherosclerosis and statins therapy: from the past to the future

Michele Buemi1, Carmela Aloisi, Floccari Fulvio

  • 1Chair of Nephrology, Department of Internal Medicine, Messina, Italy. buemim@Unime.it

Current Pharmaceutical Design
|November 25, 2005
PubMed

Insights

Atherosclerosis complications are a leading cause of death globally, increasing with social progress. Medical research aims to reduce cardiovascular disease incidence and mortality through better understanding of disease mechanisms.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Metabolic Research

Background:

  • Atherosclerosis is a primary cause of mortality in Western nations.
  • The incidence of atherosclerosis-related complications is rising in developing countries.
  • This rise correlates with increasing social and economic development.

Purpose of the Study:

  • To consolidate recent advancements in cardiovascular disease research.
  • To highlight the common goal of reducing cardiovascular disease incidence and mortality.
  • To emphasize the necessity of continued research into atherosclerosis.

Main Methods:

  • Review of studies in vascular disease.
  • Analysis of research on lipid and glucose metabolism.
  • Examination of clinical, epidemiologic, and pharmacologic research on arterial diseases.

Main Results:

  • Significant scientific progress has been made in understanding atherosclerosis.
  • Improved comprehension of pathogenic mechanisms underlying cardiovascular disease progression.
  • Concentrated research efforts across multiple medical disciplines.

Conclusions:

  • Atherosclerosis poses a growing global health challenge.
  • Multidisciplinary research is crucial for mitigating cardiovascular disease.
  • Continued scientific inquiry is essential to combat cardiovascular mortality.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...